NEW YORK, Feb. 2 (GenomeWeb News) - NuGen Technologies has signed agreements with MediBic of Japan and TouchDown Biomarketing in Europe to help it market and sell its RNA-amplification products in Asia and Europe, respectively, the company said yesterday.
San Carlos, Calif.-based NuGen also said it has opened a sales office in Europe, which will be managed by TouchDown. NuGen's European sales team will work with TouchDown to launch the company's RNA-amplification systems in the European market.
MediBic, a Japanese life sciences and pharmacogenomics consulting company, will help NuGen introduce its Ovation RNA-amplification products throughout Asia.
TouchDown is based in Gendt, The Netherlands, and MediBic is located in Tokyo.